TrialBritish journal of cancer2013

Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer.

S Mitsunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.